Cargando…
CLEC16A—An Emerging Master Regulator of Autoimmunity and Neurodegeneration
CLEC16A is emerging as an important genetic risk factor for several autoimmune disorders and for Parkinson disease (PD), opening new avenues for translational research and therapeutic development. While the exact role of CLEC16A in health and disease is still being elucidated, the gene plays a criti...
Autores principales: | Pandey, Rahul, Bakay, Marina, Hakonarson, Hakon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10179542/ https://www.ncbi.nlm.nih.gov/pubmed/37175930 http://dx.doi.org/10.3390/ijms24098224 |
Ejemplares similares
-
JAK/STAT inhibitor therapy partially rescues the lipodystrophic autoimmune phenotype in Clec16a KO mice
por: Pandey, Rahul, et al.
Publicado: (2021) -
The Autoimmune Disorder Susceptibility Gene CLEC16A Restrains NK Cell Function in YTS NK Cell Line and Clec16a Knockout Mice
por: Pandey, Rahul, et al.
Publicado: (2019) -
Inducible knockout of Clec16a in mice results in sensory neurodegeneration
por: Hain, Heather S., et al.
Publicado: (2021) -
CLEC16A regulates splenocyte and NK cell function in part through MEK signaling
por: Pandey, Rahul, et al.
Publicado: (2018) -
SOCS-JAK-STAT inhibitors and SOCS mimetics as treatment options for autoimmune uveitis, psoriasis, lupus, and autoimmune encephalitis
por: Pandey, Rahul, et al.
Publicado: (2023)